Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy

Conditions:   Head and Neck Squamous Cell Carcinoma;   Head and Neck Cancer
Interventions:   Drug: Pembrolizumab;   Drug: Epacadostat
Sponsor:   University of Chicago
Not yet recruiting

http://ift.tt/2IkAXTA